Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoxiang Shen

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Life Sciences|July 11, 2006
Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarrayRong Hu, Changjiang Xu, Guoxiang Shen, et al.
Molecular Carcinogenesis|June 2, 2006
Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cellsXiaoling Yuan, Changjiang Xu, Zui Pan, et al.
Biopharmaceutics & Drug Disposition|September 5, 2006
Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ miceTin Oo Khor, Rong Hu, Guoxiang Shen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 26, 2012
Development of a carbon-14 labeling approach to support disposition studies with a pegylated biologicHaiqing Wang, Lifei Wang, Kai Cao, et al.
Cancer Research|October 19, 2007
Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouseGuoxiang Shen, Tin Oo Khor, Rong Hu, et al.
Biopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its dispositionWen Lin, Jin-Liern Hong, Guoxiang Shen, et al.
Pharmaceutical Research|September 14, 2006
Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J miceSujit Nair, Changjiang Xu, Guoxiang Shen, et al.
Cancer Research|January 21, 2006
Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient miceTin Oo Khor, Young-Sam Keum, Wen Lin, et al.
The Oncologist|September 15, 2017
FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior TherapyVishal Bhatnagar, Nicole J Gormley, Lola Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple MyelomaAndrea C Baines, Rachel Ershler, Bindu Kanapuru, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Life Sciences|July 11, 2006
Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarrayRong Hu, Changjiang Xu, Guoxiang Shen, et al.
Molecular Carcinogenesis|June 2, 2006
Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cellsXiaoling Yuan, Changjiang Xu, Zui Pan, et al.
Biopharmaceutics & Drug Disposition|September 5, 2006
Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ miceTin Oo Khor, Rong Hu, Guoxiang Shen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 26, 2012
Development of a carbon-14 labeling approach to support disposition studies with a pegylated biologicHaiqing Wang, Lifei Wang, Kai Cao, et al.
Cancer Research|October 19, 2007
Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouseGuoxiang Shen, Tin Oo Khor, Rong Hu, et al.
Biopharmaceutics & Drug Disposition|February 23, 2011
Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its dispositionWen Lin, Jin-Liern Hong, Guoxiang Shen, et al.
Pharmaceutical Research|September 14, 2006
Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J miceSujit Nair, Changjiang Xu, Guoxiang Shen, et al.
Cancer Research|January 21, 2006
Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient miceTin Oo Khor, Young-Sam Keum, Wen Lin, et al.
The Oncologist|September 15, 2017
FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior TherapyVishal Bhatnagar, Nicole J Gormley, Lola Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple MyelomaAndrea C Baines, Rachel Ershler, Bindu Kanapuru, et al.
Pageof 5